| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |